Alendronate Increased Bone Mineral Density but Did Not Reduce New Fractures in Glucocorticoid Induced Osteoporosis

Gut - United Kingdom
doi 10.1136/gut.44.6.780
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Bone Mineral Density Measurement and Treatment for Osteoporosis in Older Individuals With Fractures

Archives of Internal Medicine
2003English

Vertebral Fractures and Bone Mineral Density in Idiopathic, Secondary and Corticosteroid Associated Osteoporosis in Men

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2000English

Glucocorticoid-Induced Osteoporosis

RMD Open
RheumatologyAllergyImmunology
2015English

Letter: Nonalcoholic Fatty Liver Disease Is Associated With a History of Osteoporotic Fractures but Not With Low Bone Mineral Density

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2019English

Association Analysis of the COL1A1 Polymorphism With Bone Mineral Density and Prevalent Fractures in Polish Postmenopausal Women With Osteoporosis

Archives of Medical Science
Medicine
2016English

Effects of Combined Treatment With Alendronate and Alfacalcidol on Bone Mineral Density and Bone Turnover in Postmenopausal Osteoporosis: A Two-Years, Randomized, Multiarm, Controlled Trial

The Internet Journal of Epidemiology
2007English

Bone Mineral Density Deficits and Fractures in Survivors of Childhood Cancer

Current Osteoporosis Reports
EndocrinologyMetabolismDiabetes
2013English

Bone Tissue Properties Measurement by Reference Point Indentation in Glucocorticoid-Induced Osteoporosis

Journal of Bone and Mineral Research
EndocrinologyOrthopedicsSports MedicineMetabolismDiabetes
2015English

The Relationship Between Fetuin-A and Bone Mineral Density in Postmenopausal Osteoporosis

Turkish Journal of Rheumatology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy